20135 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Abuse resistant forms of extended release hydrocodone, method of use and method of making
#1202Compositions and methods for treating metabolic disorders
#1203Abuse resistant forms of extended release oxymorphone, method of use and method of making
#1204Abuse resistant forms of immediate release hydromorphone, method of use and method of making
#1205Controlled-release solid dosage forms of mesalamine
#1206Enteric coated multiparticulate composition with proteinaceous subcoat
#1207Treating pain in patients with hepatic impairment
#1208Combination product comprising phentermine and topiramate, and preparation method thereof
#1209DOSAGE FORM COMPRISING A STEROID 5-ALPHA-REDUCTASE INHIBITOR AND AN ALPHA BLOCKER, PROCESS FOR PREPARING OF A DOSAGE FORM, USE OF DOSAGE FORM, METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A DISEASE OR CONDITION MEDIATED BY ANDROGEN
#1210Pharmaceutical compositions for the treatment of
#1211ABUSE RESISTANT FORMS OF IMMEDIATE RELEASE OXYCODONE, METHOD OF USE AND METHOD OF MAKING
#1212Process for the preparation of a solid, orally administrable pharmaceutical composition
#1213PHARMACEUTICAL COMPOSITIONS OF LEVODOPA AND CARBIDOPA
#1214METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#1215Swallowable drug delivery device and method of delivery
#1216LIQUID-FILLED HARD GEL CAPSULE PHARMACEUTICAL FORMULATIONS
#1217Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses Thereof
#1218Methods and compositions for treating diabetes
#1219CARBIDOPA/LIPODOPA GASTRORETENTIVE DRUG DELIVERY
#1220CONTROLLED RELEASE PREPARATIONS
#1221Method and composition for treating alzheimer-type dementia
#1222Tamper-resistant pharmaceutical compositions of opioids and other drugs
#1223Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#1224METHODS FOR PREPARING CELL DELIVERY MATRICES
#1225Abuse resistant forms of extended release morphine, method of use and method of making
#1226Controlled release oral pharmaceutical dosage forms comprising MGBG
#1227Device having titania nanotube membrane for drug delivery
#1228Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
#1229Polymer conjugated protein micelles
#12305-aminosalicyclic acid capsule formulation
#1231Method and apparatus for forming delivery devices for oral intake of an agent
#1232Composition and method for treating neurological disease
#1233Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
#1234Antibody-conjugated double-emulsion nanocapsule and preparation methods thereof
#1235Sustained release capsules
#1236Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#1237Capsule for encapsulating a tablet
#1238Composition and method for treating neurological disease
#1239Composition and method for treating neurological disease
#1240Composition and method for treating neurological disease
#1241Composition and method for treating neurological disease
#1242Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#1243TAMPER RESISTANT PHARMACEUTICAL FORMULATIONS
#1244Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#1245Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
#1246Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#1247Milrinone controlled-release formulation
#1248Optimal colon targeting technology
#1249PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND AN H2 RECEPTOR ANTAGONIST
#1250Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
#1251CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM
#1252Carbidopa/levodopa gastroretentive drug delivery
#1253Drug Delivery Device Comprising Silicon-Based Carrier Particles
#1254METHOD OF TREATING ACNE
#1255Krill oil and reacted astaxanthin composition and associated method
#1256Delivery system for saw palmetto extract and carotenoid
#1257Capsule with internal diaphragm
#1258Orally effective methylphenidate extended release powder and aqueous suspension product
#1259Tamper resistant pharmaceutical formulations
#1260Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
#1261Gastroretentive dosage system and process of preparation thereof
#1262COATED SUBSTRATE COMPOSITIONS
#1263Extended-release topiramate capsules
#1264Doxycycline Formulations, and Methods of Treating Rosacea
#1265METHOD FOR PREPARING NANOLIPIDS WITH ENCAPSULATED ALCOHOL
#1266Method for delivering a therapeutic agent into the wall of the small intestine
#1267Formulation of diclofenac
#1268Solid, orally administrable pharmaceutical composition
#1269Abuse resistant forms of extended release morphine, method of use and method of making
#1270Abuse resistant forms of extended release morphine, method of use and method of making
#1271ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS
#1272Granular Pharmaceutical Composition
#1273NICOTINAMIDE COMPOSITIONS AND THE THERAPEUTIC USE THEREOF
#1274Composite formulation comprising a tablet encapsulated in a hard capsule
#1275Pharmaceutical compositions for the treatment of
#1276CAPSULE WHOSE ENVELOPE IS SEPARATELY IMPERCEPTIBLE DURING THE TOPICAL USE THEREOF
#1277Device, system and methods for the oral delivery of therapeutic compounds
#1278Swallowable drug delivery device and methods of drug delivery
#1279Formulation of diclofenac
#1280MULTILAYERED POLYELECTROLYTE-BASED CAPSULES FOR CELL ENCAPSULATION AND DELIVERY OF THERAPEUTIC COMPOSITIONS
#1281Compositions for treatment of attention deficit hyperactivity disorder
#1282Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same
#1283Stable solid preparations
#1284CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1285CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1286Compositions and methods for treating centrally mediated nausea and vomiting
#1287Compositions and methods for treating centrally mediated nausea and vomiting
#1288ORAL DOSAGE FORMS WITH THERAPEUTICALLY ACTIVE AGENTS IN CONTROLLED RELEASE CORES AND IMMEDIATE RELEASE GELATIN CAPSULE COATS
#1289Compositions and methods for treating centrally mediated nausea and vomiting
#1290ORAL DOSAGE FORMS WITH THERAPEUTICALLY ACTIVE AGENTS IN CONTROLLED RELEASE CORES AND IMMEDIATE RELEASE GELATIN CAPSULE COATS
#1291Pharmaceutical composition containing diamine derivative
#1292CAPSULE FORMULATION COMPRISING MONTELUKAST AND LEVOCETIRIZINE
#1293Stable digestive enzyme compositions
#1294Pharmaceutical composition
#1295Solid ganaxolone compositions and methods for the making and use thereof
#12965-AMINOSALICYLIC ACID CAPSULE FORMULATION
#1297Swallowable medication capsule
#1298VECTOR FOR ORAL ADMINISTRATION
#1299ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS
#1300FILM COATING FOR TABLETS AND CAPLETS
#1301Tamper-resistant oral opioid agonist formulations
#1302CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1303CAPSULES COMPRISING AN EMULSIFIED SYRUP AND METHODS OF MAKING THE SAME
#1304Gas Storage Vessel, Hydrogen-Charging Method, and Hydrogen-Charging Apparatus
#1305Microfabricated nanopore device for sustained release of therapeutic agent
#1306Microfabricated nanopore device for sustained release of therapeutic agent
#1307Once daily formulations of tetracyclines
#1308Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#1309Formulations of histone deacetylase inhibitor and uses therof
#1310PHARMACEUTICAL COMPOSITIONS OF MEMANTINE
#1311Layered Bodies, Compositions Containing Them and Processes for Producing Them
#1312Microfabricated nanopore device for sustained release of therapeutic agent
#1313Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
#1314Pharmaceutical Composition
#1315Chemosensory receptor ligand-based therapies
#1316CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION
#1317Pharmaceutical compositions
#1318ACCORDION PILL COMPRISING LEVODOPA FOR AN IMPROVED TREATMENT OF PARKINSON'S DISEASE SYMPTOMS
#1319Series of capsules comprising at least one drop of internal phase in a drop of intermediate phase and manufacturing method thereof
#1320Abuse and alcohol resistant drug composition
#1321Device and installation for joining at least two medicine capsules by adhesive bonding
#1322MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS MEMANTINE
#1323Orally effective methylphenidate extended release powder and aqueous suspension product
#1324Micronized Tanaproget and Compositions Containing Same
#1325Medical Devices and Implements with Liquid-Impregnated Surfaces
#1326Pharmaceutical Compositions Containing Dimethyl Fumarate
#1327Liquid ganaxolone formulations and methods for the making and use thereof
#1328Sustained drug delivery system
#1329Capsule which disintegrates specifically in the large intestine
#1330PHARMACEUTICAL COMPOSITION COMPRISING PHENTERMINE AND TOPIRAMATE
#1331Pharmaceutical formulation containing gelling agent
#1332Pharmaceutical Forms and Methods for Designing the Same
#1333Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
#1334Nanocapsules containing microemulsions
#1335Microfabricated nanopore device for sustained release of therapeutic agent
#1336Formulations and dosage forms of oxidized phospholipids
#1337Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1338Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1339Method and apparatus for manufacturing a capsule
#1340Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1341Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1342Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1343Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1344Device, system and methods for the oral delivery of therapeutic compounds
#1345Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1346Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1347Solid dosage form that promotes reliable oral, esophageal and GI transit
#1348MULTI-PHASE, MULT-COMPARTMENT CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME
#1349Composition comprising shellac and/or a salt thereof and sodium starch glycolate
#1350Diversion-resistant microgranules and microtablets
#1351Liquid-filled hard gel capsule pharmaceutical formulations
#1352LIPOSOMAL FORMULATION FOR ORAL ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA GEL CAPSULE
#1353Method for treating celiac disease
#1354Floating gastric retentive dosage form
#1355Dual controlled release dosage form
#1356PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION OF A MEDICAMENT
#1357COMPOSITIONS AND METHODS FOR TREATING OBESITY AND OBESITY-RELATED CONDITIONS
#1358PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#1359Miniature ingestible device
#1360Progesterone containing oral dosage forms and kits
#1361Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
#1362GASTRIC ACID SECRETION INHIBITING COMPOSITION
#1363MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#1364METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS
#1365Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#1366Orally effective methylphenidate extended release powder and aqueous suspension product
#1367Utilization of dialkylfumarates
#1368COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF
#1369NOVEL GASTRORETENTIVE DOSAGE FORMS OF POORLY SOLUBLE DRUGS
#1370CAPSULE FOR ORAL PET MEDICINE
#1371Ingestible device with pharmaceutical product
#1372SUPPOSITORY COMPRISING PANTOPRAZOLE
#1373COMPRESSED CORE FOR PHARMACEUTICAL COMPOSITION
#1374Tamper-resistant oral opioid agonist formulations
#1375Methods for the Treatment of CNS-Related Conditions
#1376ORGANIC COMPOUNDS
#1377Delayed release pharmaceutical composition of mesalamine
#1378Cofactors and Methods for Use for Individuals
#1379Delayed release oral pharmaceutical dosage forms comprising MGBG
#1380Colon vitamin
#1381Methods for the treatment of CNS-related conditions
#1382Compositions for the treatment of CNS-related conditions
#1383Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
#1384CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#1385Devices and methods for weight control and weight loss
#1386ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#1387DEXLANSOPRAZOLE COMPOSITIONS
#1388Orally effective methylphenidate extended release powder and aqueous suspension product
#1389Dosage forms for tamper prone therapeutic agents
#1390METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS
#1391Pharmaceutical compositions for the deterrence and/or prevention of abuse
#1392MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#1393Pharmaceutical compositions
#1394Pharmaceutical formulation
#1395Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
#1396Stable low digestive enzyme content formulation
#1397COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#1398MULTILAYERED POLYELECTROLYTE-BASED CAPSULES FOR CELL ENCAPSULATION AND DELIVERY OF THERAPEUTIC COMPOSITIONS
#1399Pharmaceutical Compositions
#1400Chemosensory Receptor Ligand-Based Therapies
#1401Sustained drug delivery system
#1402STABLE COMBINATIONS OF AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
#1403PHARMACEUTICAL FORMULATIONS
#1404DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME
#1405CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#1406PULSATILE RELEASE PHARMACEUTICAL FORMULATION OF DEXLANSOPRAZOLE
#1407Abuse resistant oral opioid formulations
#1408BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES
#1409Abuse resistant forms of immediate release oxycodone, method of use and method of making
#1410Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
#1411Solid dosage form that promotes reliable oral, esophageal and GI transit
#1412Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
#1413Liposome-encapsulated glutathione for oral administration
#1414Formulation of diclofenac
#1415Timed, pulsatile release systems
#1416Sustained release capsules
#1417Pharmaceutical Composition
#1418Gastric Acid Secretion Inhibiting Composition
#1419Modular ingestible drug delivery capsule
#1420Tanaproget compositions containing ethinyl estradiol
#1421Pharmaceutical formulation containing gelling agent
#1422Pellets for Delivery of Biologically Active Substances
#1423CONTROLLED RELEASE COMPOSITIONS COMPRISING A COMBINATION OF ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
#1424Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions
#1425PRESERVATIVE-FREE PHARMACEUTICAL TETRAHYDROLIPSTATIN COMPOSITIONS
#1426Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
#1427PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#1428Compositions and methods for treating centrally mediated nausea and vomiting
#1429Ingestible event markers comprising an ingestible component
#1430Apparatus and process for encapsulating microparticles with liquid in soft gel capsules
#1431Methods and systems for prolonged localization of drug delivery
#1432Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
#1433Liquid ganaxolone formulations and methods for the making and use thereof
#1434FIXED DOSE DRUG COMBINATION FORMULATIONS
#1435ORAL DRUG DEVICES AND DRUG FORMULATIONS
#1436SGLT2 INHIBITOR DOSAGE FORMS
#1437PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY
#1438METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE
#1439Stable pharmaceutical composition for atherosclerosis
#1440Cell lines and their use in encapsulated cell biodelivery
#1441Zaleplon gastroretentive drug delivery system
#1442Single daily dosage form for prevention and treatment of metabolic syndrome
#1443Enterically coated cysteamine, cystamine and derivatives thereof
#1444NOVEL GASTRO-RETENTIVE DOSAGE FORMS
#1445Swallowable drug delivery device and method of delivery
#1446LEVETIRACETAM CONTROLLED RELEASE COMPOSITION
#1447Once daily formulations of tetracyclines
#1448Drug coating providing high drug loading and methods for providing the same
#1449NSAID DOSE UNIT FORMULATIONS WITH H2-RECEPTOR ANTAGONISTS AND METHODS OF USE
#1450Progesterone Containing Oral Dosage Forms and Related Methods
#1451Progesterone Containing Oral Dosage Forms and Related Methods
#1452Formulations of histone deacetylase inhibitor and uses thereof
#1453METHOD FOR ADDING SENSORY CONDITIONING CUES IN A PHARMACOTHERAPEUTIC REGIMEN
#1454Liposome-encapsulated glutathione for oral administration
#1455Pharmaceutical Formulation
#1456Once daily formulations of tetracyclines
#1457PHARMACEUTICAL FORMULATIONS COMPRISING NSAID AND PROTON PUMP INHIBITOR DRUGS
#1458Utilization of dialkylfumarates
#1459Once daily formulations of tetracyclines
#1460ORAL DOSAGE FORMS WITH THERAPEUTICALLY ACTIVE AGENTS IN CONTROLLED RELEASE CORES AND IMMEDIATE RELEASE GELATIN CAPSULE COATS
#1461METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING
#1462Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
#1463Controlled release hydrocodone formulations
#1464PULSATILE RELEASE COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL DRUG ABSORPTION
#1465SPACED DRUG DELIVERY SYSTEM
#1466Compositions and methods for inhibiting gastric acid secretion
#1467INJECTION-MOULDED WATER-SOLUBLE CONTAINER
#1468Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation
#1469Stabilized formulations of CNS compounds
#1470Dosage Forms
#1471Solid ganaxolone formulations and methods for the making and use thereof
#1472Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
#1473ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS
#1474Microfabricated nanopore device for sustained release of therapeutic agent
#1475COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#1476Modified Release Dosage Forms of Skeletal Muscle Relaxants
#1477Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
#1478Method of administering amantadine prior to a sleep period
#1479Colon lavage system
#1480Pharmaceutical compositions configured to deter dosage form splitting
#1481Oral Formulation
#1482Capsule with soluble blocking element
#1483SUSTAINED RELEASE FORMULATION FOR VENLAFAXINE HYDROCHLORIDE
#1484Immediate release compositions of acid labile drugs
#1485SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#1486Swallowable drug delivery device and methods of drug delivery
#1487Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#1488Abuse resistant drugs, method of use and method of making
#1489Abuse resistant forms of extended release morphine, method of use and method of making
#1490Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making
#1491Abuse resistant forms of extended release hydrocodone, method of use and method of making
#1492Abuse resistant forms of extended release oxymorphone, method of use and method of making
#1493Abuse resistant forms of extended release oxycodone, method of use, and method of making
#1494Abuse resistant forms of extended release hydromorphone, method of use and method of making
#1495Tamper-resistant pharmaceutical compositions of opioids and other drugs
#1496Film coating for tablets and caplets
#1497MODIFIED RELEASE RAMIPRIL COMPOSITIONS AND USES THEREOF
#1498Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, prepartion, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
#1499Lipoic acid pellet composition
#1500Stable digestive enzyme compositions